Whittington, M. D., McQueen, R. B., Ollendorf, D. A., Kumar, V. M., Chapman, R. H., Tice, J. A., . . . Campbell, J. D. (2018). Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia. JAMA Pediatr.
Citação norma ChicagoWhittington, Melanie D., R. Brett McQueen, Daniel A. Ollendorf, Varun M. Kumar, Richard H. Chapman, Jeffrey A. Tice, Steven D. Pearson, and Jonathan D. Campbell. "Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia." JAMA Pediatr 2018.
Citação norma MLAWhittington, Melanie D., et al. "Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia." JAMA Pediatr 2018.